These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36882513)

  • 1. Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness.
    Chen J; Qiu S; Li W; Wang K; Zhang Y; Yang H; Liu B; Li G; Li L; Chen M; Lan J; Niu J; He P; Cheng L; Fan G; Liu X; Song X; Xu C; Wu H; Wang H
    Cell Res; 2023 May; 33(5):341-354. PubMed ID: 36882513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of CAR-Mediated Tonic Signaling.
    Calderon H; Mamonkin M; Guedan S
    Methods Mol Biol; 2020; 2086():223-236. PubMed ID: 31707680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.
    Bai Z; Lundh S; Kim D; Woodhouse S; Barrett DM; Myers RM; Grupp SA; Maus MV; June CH; Camara PG; Melenhorst JJ; Fan R
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006631
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Suematsu M; Yagyu S; Nagao N; Kubota S; Shimizu Y; Tanaka M; Nakazawa Y; Imamura T
    Front Immunol; 2022; 13():770132. PubMed ID: 35154098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.
    Drent E; Poels R; Ruiter R; van de Donk NWCJ; Zweegman S; Yuan H; de Bruijn J; Sadelain M; Lokhorst HM; Groen RWJ; Mutis T; Themeli M
    Clin Cancer Res; 2019 Jul; 25(13):4014-4025. PubMed ID: 30979735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to Address Chimeric Antigen Receptor Tonic Signaling.
    Ajina A; Maher J
    Mol Cancer Ther; 2018 Sep; 17(9):1795-1815. PubMed ID: 30181329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of antitumor chimeric antigen receptors incorporating T cell signaling motifs.
    Balagopalan L; Moreno T; Qin H; Angeles BC; Kondo T; Yi J; McIntire KM; Alvinez N; Pallikkuth S; Lee ME; Yamane H; Tran AD; Youkharibache P; Cachau RE; Taylor N; Samelson LE
    Sci Signal; 2024 Jul; 17(846):eadp8569. PubMed ID: 39042728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The persistence and antitumor efficacy of CAR-T cells are modulated by tonic signaling within the CDR.
    Zhou J; Shi F; Luo X; Lei B; Shi Z; Huang C; Zhang Y; Li X; Wang H; Li XY; He X
    Int Immunopharmacol; 2024 Jan; 126():111239. PubMed ID: 37979453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors.
    Fisher J; Sharma R; Don DW; Barisa M; Hurtado MO; Abramowski P; Porter L; Day W; Borea R; Inglott S; Anderson J; Pe'er D
    Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric Antigen Receptor T Cell Bearing Herpes Virus Entry Mediator Co-Stimulatory Signal Domain Exhibits Exhaustion-Resistant Properties.
    Nunoya JI; Imuta N; Masuda M
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.
    Kagoya Y; Tanaka S; Guo T; Anczurowski M; Wang CH; Saso K; Butler MO; Minden MD; Hirano N
    Nat Med; 2018 Mar; 24(3):352-359. PubMed ID: 29400710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.
    Salter AI; Ivey RG; Kennedy JJ; Voillet V; Rajan A; Alderman EJ; Voytovich UJ; Lin C; Sommermeyer D; Liu L; Whiteaker JR; Gottardo R; Paulovich AG; Riddell SR
    Sci Signal; 2018 Aug; 11(544):. PubMed ID: 30131370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines.
    Schneider D; Xiong Y; Wu D; Nӧlle V; Schmitz S; Haso W; Kaiser A; Dropulic B; Orentas RJ
    J Immunother Cancer; 2017; 5():42. PubMed ID: 28515942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy.
    Giardino Torchia ML; Gilbreth R; Merlino A; Sult E; Monks N; Chesebrough J; Tammali R; Chu N; Tong J; Meekin J; Schifferli K; Vashisht K; DaCosta K; Clarke L; Gesse C; Yao XT; Bridges C; Moody G
    Cytotherapy; 2022 Jul; 24(7):720-732. PubMed ID: 35570170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.
    Long AH; Haso WM; Shern JF; Wanhainen KM; Murgai M; Ingaramo M; Smith JP; Walker AJ; Kohler ME; Venkateshwara VR; Kaplan RN; Patterson GH; Fry TJ; Orentas RJ; Mackall CL
    Nat Med; 2015 Jun; 21(6):581-90. PubMed ID: 25939063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity.
    Vander Mause ER; Atanackovic D; Lim CS; Luetkens T
    Trends Biotechnol; 2022 Jul; 40(7):875-890. PubMed ID: 35078657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining chimeric antigen receptors via barcoded protein domain combination pooled screening.
    Rios X; Pardias O; Morales MA; Bhattacharya P; Chen Y; Guo L; Zhang C; Di Pierro EJ; Tian G; Barragan GA; Sumazin P; Metelitsa LS
    Mol Ther; 2023 Nov; 31(11):3210-3224. PubMed ID: 37705245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells.
    Seitz CM; Schroeder S; Knopf P; Krahl AC; Hau J; Schleicher S; Martella M; Quintanilla-Martinez L; Kneilling M; Pichler B; Lang P; Atar D; Schilbach K; Handgretinger R; Schlegel P
    Oncoimmunology; 2020; 9(1):1683345. PubMed ID: 32002293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells.
    Xiong W; Chen Y; Kang X; Chen Z; Zheng P; Hsu YH; Jang JH; Qin L; Liu H; Dotti G; Liu D
    Mol Ther; 2018 Apr; 26(4):963-975. PubMed ID: 29503199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking CD38-driven fratricide among T cells enables effective antitumor activity by CD38-specific chimeric antigen receptor T cells.
    Gao Z; Tong C; Wang Y; Chen D; Wu Z; Han W
    J Genet Genomics; 2019 Aug; 46(8):367-377. PubMed ID: 31466926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.